Mar 2026
Relapse-free survival and metastasis-free survival between patients with breast cancer receiving adjuvant or neoadjuvant therapy: A retrospective study in Iran
Background: Breast cancer is the most common malignancy among women in Iran and worldwide. Although both neoadjuvant and adjuvant chemotherapies are widely used, their impact on relapse-free survival (RFS) and metastasis-free survival (MFS) in real-world settings remains unclear. This study aimed to compare RFS and MFS...
Mina Azarnia, Mehran Sharifi, Z. Rezaeian et al.
· Caspian Journal of Internal... · 0 citations